Tolerability and Pharmacokinetics of Hydronidone, an Antifibrotic Agent for Hepatic Fibrosis, after Single and Multiple Doses in Healthy Subjects: an Open-Label, Randomized, Dose-Escalating, First-in-Human Study
用户unIK2n1t9Esk
1小时前
11
10
已完结
1. 当前求助状态已完结, 请及时下载应助文件
2. 系统将在 2026-03-05 16:13:55 删除文件
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
